Long-lasting dyspeptic symptoms - another consequence of the COVID-19 pandemic?

IF 1.7 Q3 GASTROENTEROLOGY & HEPATOLOGY

Przegla̜d Gastroenterologiczny Pub Date : 2023-01-01 DOI:10.5114/pg.2023.129414

Anna Nazarewska, Konrad Lewandowski, Magdalena Kaniewska, Edyta Tulewicz-Marti, Martyna Więcek, Paulina Szwarc, Mariusz Rosołowski, Wojciech Marlicz, Grażyna Rydzewska

{"title":"Long-lasting dyspeptic symptoms - another consequence of the COVID-19 pandemic?","authors":"Anna Nazarewska, Konrad Lewandowski, Magdalena Kaniewska, Edyta Tulewicz-Marti, Martyna Więcek, Paulina Szwarc, Mariusz Rosołowski, Wojciech Marlicz, Grażyna Rydzewska","doi":"10.5114/pg.2023.129414","DOIUrl":null,"url":null,"abstract":"Introduction: It is known that the virus SARS-CoV-2 can attack the gastrointestinal (GI) tract and induce gastroenteritis. This can trigger a wide variety of disorders of gut-brain interaction (DGBIs) or functional gastrointestinal disorders (FGIDs), including post-infectious dyspepsia, which remains underestimated.Aim: To estimate the prevalence of dyspeptic symptoms following COVID-19, immediately after discharge and 3, 6, and 9 months after hospitalization.Material and methods: A prospective, single-centre evaluation of questions regarding functional dyspepsia (FD) as assessed by the Gastroduodenal Module of ROME IV Diagnostic Questionnaire for Adult FGIDs among 320 patients who had had COVID-19.Results: The FD ROME IV criteria were met at the respective time-points by 0.0% (0), 4.8% (12), 3.2% (8), and 3.2% (8) of cases. However, the presence of GI symptoms that suggested FD but did not meet the timeframe ROME IV criteria for FD were found in 9.6% (24), 23.5% (59), 20.7% (52), and 20.7% (52) of cases, respectively.Conclusions: The presence and persistence of gastrointestinal dyspeptic symptoms following COVID-19 is a significant problem. The timeframe of the Rome IV criteria may underestimate the number of patients with persistent dyspeptic symptoms following COVID-19 disease.","PeriodicalId":20719,"journal":{"name":"Przegla̜d Gastroenterologiczny","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/ec/PG-18-51068.PMC10395060.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Przegla̜d Gastroenterologiczny","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pg.2023.129414","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: It is known that the virus SARS-CoV-2 can attack the gastrointestinal (GI) tract and induce gastroenteritis. This can trigger a wide variety of disorders of gut-brain interaction (DGBIs) or functional gastrointestinal disorders (FGIDs), including post-infectious dyspepsia, which remains underestimated.

Aim: To estimate the prevalence of dyspeptic symptoms following COVID-19, immediately after discharge and 3, 6, and 9 months after hospitalization.

Material and methods: A prospective, single-centre evaluation of questions regarding functional dyspepsia (FD) as assessed by the Gastroduodenal Module of ROME IV Diagnostic Questionnaire for Adult FGIDs among 320 patients who had had COVID-19.

Results: The FD ROME IV criteria were met at the respective time-points by 0.0% (0), 4.8% (12), 3.2% (8), and 3.2% (8) of cases. However, the presence of GI symptoms that suggested FD but did not meet the timeframe ROME IV criteria for FD were found in 9.6% (24), 23.5% (59), 20.7% (52), and 20.7% (52) of cases, respectively.

Conclusions: The presence and persistence of gastrointestinal dyspeptic symptoms following COVID-19 is a significant problem. The timeframe of the Rome IV criteria may underestimate the number of patients with persistent dyspeptic symptoms following COVID-19 disease.

查看原文本刊更多论文

长期消化不良症状——COVID-19大流行的另一个后果?

简介:众所周知，SARS-CoV-2病毒可攻击胃肠道，诱发肠胃炎。这可能引发多种肠-脑相互作用紊乱(DGBIs)或功能性胃肠道紊乱(fgid)，包括感染后消化不良，这仍然被低估。目的:评估COVID-19后、出院后立即以及住院后3、6和9个月消化不良症状的发生率。材料和方法:对320例COVID-19患者的功能性消化不良(FD)问题进行前瞻性、单中心评估，该问题由ROME IV成人fgid诊断问卷的胃十二指肠模块评估。结果:分别有0.0%(0)、4.8%(12)、3.2%(8)和3.2%(8)的病例在各自的时间点符合FD ROME IV标准。然而，在9.6%(24例)、23.5%(59例)、20.7%(52例)和20.7%(52例)的病例中，存在提示FD但不符合FD时间框架ROME IV标准的胃肠道症状。结论:新型冠状病毒感染后胃肠道消化不良症状的存在和持续是一个重要问题。罗马IV标准的时间框架可能低估了COVID-19疾病后出现持续消化不良症状的患者数量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Przegla̜d Gastroenterologiczny GASTROENTEROLOGY & HEPATOLOGY-

CiteScore

2.20

自引率

7.70%

发文量

审稿时长

6-12 weeks

期刊介绍： Gastroenterology Review is a journal published each 2 months, aimed at gastroenterologists and general practitioners. Published under the patronage of Consultant in Gastroenterology and Polish Pancreatic Club.